Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 21017 | 375 | 24.3 | 43% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | REMOXIPRIDE | Author keyword | 17 | 38% | 9% | 35 |
| 2 | DA D2 RECEPTORS | Author keyword | 1 | 50% | 0% | 1 |
| 3 | DOPAMINE D 2 ANTAGONISTS | Author keyword | 1 | 50% | 0% | 1 |
| 4 | EXTRAPOLATION ESCAPE TEST | Author keyword | 1 | 50% | 0% | 1 |
| 5 | LEIDEN AMSTERDAM DRUG PHARMACOL | Address | 1 | 50% | 0% | 1 |
| 6 | D2 ANTAGONISTS | Author keyword | 0 | 33% | 0% | 1 |
| 7 | SIDE EFFECTS DRUG | Author keyword | 0 | 33% | 0% | 1 |
| 8 | TIRACIZINE | Author keyword | 0 | 33% | 0% | 1 |
| 9 | BEHAV BIOCHEM PHARMACOL | Address | 0 | 20% | 0% | 1 |
| 10 | DAY NIGHT VARIATIONS | Author keyword | 0 | 20% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | REMOXIPRIDE | 17 | 38% | 9% | 35 | Search REMOXIPRIDE | Search REMOXIPRIDE |
| 2 | DA D2 RECEPTORS | 1 | 50% | 0% | 1 | Search DA+D2+RECEPTORS | Search DA+D2+RECEPTORS |
| 3 | DOPAMINE D 2 ANTAGONISTS | 1 | 50% | 0% | 1 | Search DOPAMINE+D+2+ANTAGONISTS | Search DOPAMINE+D+2+ANTAGONISTS |
| 4 | EXTRAPOLATION ESCAPE TEST | 1 | 50% | 0% | 1 | Search EXTRAPOLATION+ESCAPE+TEST | Search EXTRAPOLATION+ESCAPE+TEST |
| 5 | D2 ANTAGONISTS | 0 | 33% | 0% | 1 | Search D2+ANTAGONISTS | Search D2+ANTAGONISTS |
| 6 | SIDE EFFECTS DRUG | 0 | 33% | 0% | 1 | Search SIDE+EFFECTS+DRUG | Search SIDE+EFFECTS+DRUG |
| 7 | TIRACIZINE | 0 | 33% | 0% | 1 | Search TIRACIZINE | Search TIRACIZINE |
| 8 | DAY NIGHT VARIATIONS | 0 | 20% | 0% | 1 | Search DAY+NIGHT+VARIATIONS | Search DAY+NIGHT+VARIATIONS |
| 9 | H 3RACLOPRIDE BINDING | 0 | 20% | 0% | 1 | Search H+3RACLOPRIDE+BINDING | Search H+3RACLOPRIDE+BINDING |
| 10 | DOUBLE BLIND TRIALS | 0 | 14% | 0% | 1 | Search DOUBLE+BLIND+TRIALS | Search DOUBLE+BLIND+TRIALS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | COMPARING REMOXIPRIDE | 9 | 83% | 1% | 5 |
| 2 | POTENTIAL ANTIPSYCHOTIC COMPOUND | 8 | 100% | 1% | 5 |
| 3 | POTENTIAL NEUROLEPTIC AGENTS | 3 | 39% | 2% | 7 |
| 4 | ANTIDOPAMINERGIC PROPERTIES | 3 | 31% | 2% | 9 |
| 5 | NEUROLEPTIC AGENTS | 3 | 35% | 2% | 7 |
| 6 | ZETIDOLINE | 2 | 67% | 1% | 2 |
| 7 | SALICYLAMIDE | 2 | 19% | 2% | 8 |
| 8 | REMOXIPRIDE | 2 | 15% | 3% | 10 |
| 9 | ANTAGONIST REMOXIPRIDE | 1 | 100% | 1% | 2 |
| 10 | ORTHO ANISAMIDES | 1 | 100% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| REMOXIPRIDE IN PARKINSONS-DISEASE - DIFFERENTIAL RESPONSE IN PATIENTS WITH DYSKINESIAS FLUCTUATIONS VERSUS PSYCHOSIS | 1995 | 13 | 11 | 45% |
| Pharmacology of the atypical antipsychotic remoxipride, a dopamine D-2 receptor antagonist | 2001 | 14 | 117 | 38% |
| A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride | 2008 | 20 | 88 | 19% |
| PREFRONTAL CORTICAL DOPAMINE SYSTEMS AND THE ELABORATION OF FUNCTIONAL CORTICOSTRIATAL CIRCUITS - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE | 1993 | 171 | 98 | 8% |
| Biomarkers for the effects of antipsychotic drugs in healthy volunteers | 2001 | 39 | 87 | 13% |
| CONFORMATIONALLY DEFINED PYRROLOISOQUINOLINE ANTIPSYCHOTICS - IMPLICATIONS FOR THE MODE OF INTERACTION OF ANTI-PSYCHOTIC DRUGS WITH THE DOPAMINE RECEPTOR | 1983 | 12 | 3 | 67% |
| CLINICAL-TRIALS OF BENZAMIDES IN PSYCHIATRY | 1982 | 22 | 4 | 75% |
| NOVEL DOPAMINE-D-2 ANTAGONISTS FOR THE TREATMENT OF SCHIZOPHRENIA | 1988 | 9 | 20 | 30% |
| NEUROCHEMICAL EFFECTS OF PROLONGED TREATMENT WITH REMOXIPRIDE AS ASSESSED BY INTRACEREBRAL MICRODIALYSIS IN FREELY MOVING RATS | 1994 | 1 | 26 | 27% |
| THE TIME COURSE OF NEUROLEPTIC THERAPY FOR PSYCHOSIS - ROLE OF LEARNING-PROCESSES AND IMPLICATIONS FOR CONCEPTS OF PSYCHOTIC ILLNESS | 1987 | 29 | 35 | 9% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LEIDEN AMSTERDAM DRUG PHARMACOL | 1 | 50% | 0.3% | 1 |
| 2 | BEHAV BIOCHEM PHARMACOL | 0 | 20% | 0.3% | 1 |
| 3 | EXPLORATORY 1 | 0 | 20% | 0.3% | 1 |
| 4 | EXPLORATORY 2 | 0 | 14% | 0.3% | 1 |
| 5 | BIOANAL ANALYT PHARMACEUT RD | 0 | 100% | 0.3% | 1 |
| 6 | CENT S 955 KOIWAI YOSHITOMI CHO | 0 | 100% | 0.3% | 1 |
| 7 | URA 1848 | 0 | 100% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000216753 | AMISULPRIDE//LEVOSULPIRIDE//MEBEVERINE |
| 2 | 0.0000151061 | RECH PHARMACOCHIM SUBST NAT SYNTHET//3 SUBSTITUTED 1 4 BENZODIAZEPINE//AMDA |
| 3 | 0.0000131518 | C 11RACLOPRIDE//C 11FLB 457//F 18 FALLYPRIDE |
| 4 | 0.0000130560 | SPECIALTY CHEM TECHNOL DEV//CHLOROCADMATEII//N2S LIGAND |
| 5 | 0.0000129401 | SCH 39166//DIHYDREXIDINE//DOPAMINE D1 RECEPTORS |
| 6 | 0.0000118049 | VACUOUS CHEWING MOVEMENTS//TARDIVE DYSKINESIA//OROFACIAL DYSKINESIA |
| 7 | 0.0000100443 | 1 BENZOXEPIN 5 ONES//BIOPHYS TSUKIJI 5 CHOME CHUO KU//MOTIONAL CORRELATION TIMES |
| 8 | 0.0000099691 | BENZOCAINE HYDROCHLORIDE//STATE BIOMOL ELECT// |
| 9 | 0.0000078370 | GLOBAL CHEM SCI//2 AMINOTETRALIN//2 AMINOTETRALINS |
| 10 | 0.0000070657 | DIMEBON//DIMEBOLIN//LATREPIRDINE |